Navigation Links
Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division
Date:9/22/2008

Arrowsight, Inc. announced the appointment of Suzanne Delbanco, Ph.D. as president of its newly formed health care division. Delbanco will oversee Arrowsight Medical, which focuses on helping hospitals improve the quality and safety of their care by using video to measure adherence to protocols and provide feedback on performance to hospital staff. Prior to joining Arrowsight, Delbanco was CEO of The Leapfrog Group.

Mt. Kisco, New York (PRWEB) September 22, 2008 -- Arrowsight, Inc. today announced the appointment of Suzanne Delbanco, Ph.D. as president of its newly formed health care division. Delbanco will oversee Arrowsight Medical, which focuses on helping hospitals improve the quality and safety of their care by using video to measure adherence to protocols and provide feedback on performance to hospital staff.

Prior to joining Arrowsight, Delbanco was CEO of The Leapfrog Group, a Washington, D.C.-based organization driven by major employers and other health care purchasers working to initiate breakthrough improvements in the safety, quality and affordability of care. Among other accomplishments during her tenure there from 2000-2007, the proportion of hospital ICUs staffed by intensivists -- doctors with special training in critical care -- grew from 10% to almost 30%, saving an estimated 20,000 lives annually in the U.S.

Commenting on the appointment, Arrowsight CEO Adam Aronson, who supported The Leapfrog Group as a partner member and award sponsor, said, "Suzanne Delbanco has a proven track record in pioneering efforts designed to create change. We are excited to have her on our team as we continue rolling out a groundbreaking strategy to help hospitals and other health care settings improve the delivery of patient care."

Across multiple safety-sensitive business sectors such as food processing, food services and manufacturing, Arrowsight has helped imp
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division
Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division
Other Medicine News:Health News:2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting 2Health News:2008 Lifetime Achievement Award in Heart Failure Presented During HFSA Annual Scientific Meeting 3Health News:Hurricane Devastation Touches the Nation's Blood Supply 2Health News:Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division 2Health News:Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division 3Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 2Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 3Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 4Health News:Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis 5Health News:New High Performance Brushless dc Motors From NMB 2Health News:Book Proceeds Help Cancer Patients at Phoenix Children's Hospital 2Health News:Book Proceeds Help Cancer Patients at Phoenix Children's Hospital 3
Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Discover Health Through Awareness 2Discover Health Through Awareness 3TeamStaff Inc To Announce Third Quarter Results 54190 1TeamStaff Inc To Announce Third Quarter Results 54190 2TeamStaff Inc To Announce Third Quarter Results 54190 3Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 1Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 2Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 3Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 4Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 5Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 6Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 7Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 8Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 9Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 10Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 11Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 12Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments 54187 13ValueOptions 28R 29 Awards Coordination of Benefits and Overpayment Services Contract to HMS 54184 1ValueOptions 28R 29 Awards Coordination of Benefits and Overpayment Services Contract to HMS 54184 2